Biotech investors, mark your calendars and update your watch lists with the dates and companies in this report. Major catalysts are coming down the pike for these companies in the form of FDA decisions and reports of clinical trial data. I have put together a list of companies ranging from around $100 million to just over $1 billion in market cap that are expected to be on the move within the next nine months. Some are well known and heavily traded, while others may be new to you and worthy of further investigation. >>> Discuss This Story
